Navigation Links
Nasalfent in Medical Technology

Archimedes Pharma Presents Positive Efficacy and Safety Data on Nasalfent at European Association for Palliative Care Congress

... nasalfent shows clinically meaningful pain relief within 5 m...y meaningful pain relief in 73%. All doses of nasalfent from 25mcg to 800mcg were well-tolerated, with no ...his study provides the first clinical evidence for nasalfent as an effective, acceptable and well-tolerated tre...
Nasalfent in other areas

Archimedes News (Raquo, Phase Iii, Nasalfent) @ NetFormule.com

Archimedes News. Includes Data, Morphine, Pharma, Education, Mathematics, Gang, Technology, Shoot, Bronx and Competitions information plus more related topics on ...

UPDATE 2-Warburg Pincus seeks buyer for Archimedes -source | Deals ...

* Warburg Pincus exploring options for Archimedes -source * Sales of key drug NasalFent could top $500 mln -source * Drug companies in U.S., Europe contacted ...

Healthcare Sales & Marketing Network News: Archimedes Pharma Announces ...

Archimedes Pharma Announces Ground Breaking Phase III Data Showing NasalFent to be Superior to the Standard of Care for Breakthrough Cancer Pain (HSMN NewsFeed: ...

Breakthrough Cancer Pain - Archimedes Pharma Announces First Positive ...

Archimedes Pharma Limited, the UK based, pan-European specialty pharmaceutical company, today announces positive headline Phase III results for NasalFent®, the ...

ARCHIMEDES PHARMA BEGINS PHASE III FOR NASALFENT.

Archimedes Pharma Ltd ... Nasalfent is an innovative fentanyl citrate nasal spray aimed at providing a ... Nasalfent utilises PecSysTM, a proprietary enabling ...

Archimedes Pharma Announces First Positive Phase III Clinical ...

NasalFent met the primary efficacy endpoint in study 043, a pivotal Phase III ... Patients treated with NasalFent showed a highly statistically significant ...
Other Tags
(Date:9/1/2014)... 1 September 2014: Permanent atrial fibrillation (AF) doubles the ... research in more than 6 000 patients presented at ... The findings suggest that a simple clinical assessment of ... estimate stroke risk. , Ischaemic stroke is the second ... a million deaths and many more disabled patients each ...
(Date:9/1/2014)... Bioinformatics refers to an interdisciplinary ... and genetic data. A major part of this ... tools to generate and process useful biological data. ... computation. While bioinformatics simply makes use of computers ... related concepts, biological computation refers to the subfield ...
(Date:9/1/2014)... September 01, 2014 Top10BestSEOHosting.com has ... many web host suppliers carefully, Top10BestSEOHosting.com is here ... the best web hosting suppliers in 2014. , ... clients with a top-of-the-line shared hosting plan. The ... easy-to-use platform that is affordable, accessible and powerful ...
(Date:9/1/2014)... Diego, CA (PRWEB) September 01, 2014 ... daily regarding all the latest information from the FDA ... , The US FDA announced on August 28, that ... recalled (Class I) as the device may ... the DePuy Synthes Craniomaxillofacial (CMF) Distraction System is an ...
(Date:9/1/2014)... 01, 2014 Psychogenic Non-epileptic Seizures (PNES), ... psychological disorder that can have devastating effects on those ... epileptic seizures however, they are not produced by electrical ... It is estimated that the numbers of persons ... multiple sclerosis. , Dr. Lorna Myers, Director ...
Breaking Medicine News(10 mins):Health News:Permanent AF doubles risk of stroke compared to paroxysmal AF 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3Health News:The Northeast Regional Epilepsy Group (NEREG) Offers First Conference on Psychogenic Non-epileptic Seizures (PNES) on September 20, 2014 in New Jersey 2
(Date:9/1/2014)... Boston, MA ─ Dietary quality in the U.S. has ... reduced trans fat intakebut overall dietary quality remains poor ... groups, according to a new study from Harvard School ... most direct evidence to date that the extensive efforts ... quality are having some payoff, but it also indicates ...
(Date:9/1/2014)... the alteration of a single nucleotidethe basic building block of DNAcould ... disability. The study appears in The Journal of Cell ... by a defect in a gene on the X chromosome called ... 230 women and 1 in 360 men carry a so-called premutation, ... the FMR1 gene is slightly longer than normal. These ...
(Date:8/31/2014)... a fast and accurate tool to diagnose tuberculosis ... newly developed test (TAM-TB assay) is the first ... children. The test features excellent specificity, a similar ... of a blood test. The promising findings are ... in children, particularly in tuberculosis-endemic regions. , The ...
Breaking Biology News(10 mins):Quality of US diet shows modest improvement, but overall remains poor 2Quality of US diet shows modest improvement, but overall remains poor 3A nucleotide change could initiate fragile X syndrome 2New tuberculosis blood test in children is reliable and highly specific 2
Other Contents